| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5686561 | The Journal of Urology | 2017 | 8 Pages |
Abstract
The intensity and scope of care for muscle-invasive bladder cancer should focus on the patient, disease and treatment response characteristics. This guideline attempts to improve a clinician's ability to evaluate and treat each patient, but higher quality evidence in future trials will be essential to improve level of care for these patients.
Keywords
NACAmerican Society for Radiation OncologyMIBCAUAASTRONMIBCASCOTURBTAHRQAgency for Healthcare Research and QualityAmerican Society of Clinical OncologyAmerican Urological AssociationTransurethral resection of bladder tumorRadiotherapyMuscle-invasive bladder cancernon-muscle-invasive bladder cancerUrinary bladder neoplasmsCystectomyAdjuvant chemotherapyNeoadjuvant chemotherapy
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sam S. Chang, Bernard H. Bochner, Roger Chou, Robert Dreicer, Ashish M. Kamat, Seth P. Lerner, Yair Lotan, Joshua J. Meeks, Jeff M. Michalski, Todd M. Morgan, Diane Z. Quale, Jonathan E. Rosenberg, Anthony L. Zietman, Jeffrey M. Holzbeierlein,